Patents by Inventor Wendy Luo

Wendy Luo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • P38? mitogen-activated protein kinase inhibitors
    Patent number: 11926635
    Abstract: Disclosed herein are p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and therapeutic methods of using the p38? mitogen-activated protein kinase inhibitors.
    Type: Grant
    Filed: July 19, 2022
    Date of Patent: March 12, 2024
    Assignee: GEN1E LIFESCIENCES INC.
    Inventors: Adam Galan, Wendy Luo, Ritu Lal
  • Therapeutic peptides
    Patent number: 11753445
    Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
    Type: Grant
    Filed: April 11, 2022
    Date of Patent: September 12, 2023
    Assignee: COHBAR, INC.
    Inventors: Kenneth Cundy, Remi Magnan, Kent K. Grindstaff, Wendy Luo, Yongjin Yao, Liang Zeng Yan
  • SUBSTITUTED NAPHTHYL P38ALPHA MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS
    Publication number: 20230227417
    Abstract: Substituted naphthyl p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and the use of the substituted naphthyl p38? mitogen-activated protein kinase inhibitors and pharmaceutical compositions thereof for treating diseases are disclosed.
    Type: Application
    Filed: December 5, 2022
    Publication date: July 20, 2023
    Inventors: ADAM GALAN, WENDY LUO, RITU LAL
  • P38ALPHA MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS
    Publication number: 20230090562
    Abstract: Disclosed herein are p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and therapeutic methods of using the p38? mitogen-activated protein kinase inhibitors.
    Type: Application
    Filed: July 19, 2022
    Publication date: March 23, 2023
    Inventors: ADAM GALAN, WENDY LUO, RITU LAL
  • Substituted naphthyl p38? mitogen-activated protein kinase inhibitors
    Patent number: 11555020
    Abstract: Substituted naphthyl p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and the use of the substituted naphthyl p38? mitogen-activated protein kinase inhibitors and pharmaceutical compositions thereof for treating diseases are disclosed.
    Type: Grant
    Filed: March 21, 2022
    Date of Patent: January 17, 2023
    Assignee: GEN1E LIFESCIENCES INC.
    Inventors: Adam Galan, Wendy Luo, Ritu Lal
  • SUBSTITUTED NAPHTHYL P38ALPHA MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS
    Publication number: 20220315543
    Abstract: Substituted naphthyl p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and the use of the substituted naphthyl p38? mitogen-activated protein kinase inhibitors and pharmaceutical compositions thereof for treating diseases are disclosed.
    Type: Application
    Filed: March 21, 2022
    Publication date: October 6, 2022
    Inventors: ADAM GALAN, WENDY LUO, RITU LAL
  • p38? mitogen-activated protein kinase inhibitors
    Patent number: 11440918
    Abstract: Disclosed herein are p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and therapeutic methods of using the p38? mitogen-activated protein kinase inhibitors.
    Type: Grant
    Filed: February 9, 2022
    Date of Patent: September 13, 2022
    Assignee: GEN1E LIFESCIENCES INC.
    Inventors: Adam Galan, Wendy Luo, Ritu Lal
  • CRYSTALLINE 5-(DIMETHYLAMINO)-N-(4-(MORPHOLINOMETHYL)PHENYL)NAPHTHALENE-1-SULFONAMIDE DI-HYDROCHLORIDE DI-HYDRATE
    Publication number: 20220267259
    Abstract: Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide dihydrochloride dihydrate, methods of preparing the crystalline salt, pharmaceutical compositions containing the crystalline salt, and methods of treatment using the crystalline salt are disclosed.
    Type: Application
    Filed: May 12, 2022
    Publication date: August 25, 2022
    Inventors: ADAM GALAN, RITU LAL, WENDY LUO
  • THERAPEUTIC PEPTIDES
    Publication number: 20220242912
    Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
    Type: Application
    Filed: April 11, 2022
    Publication date: August 4, 2022
    Inventors: Kenneth Cundy, Remi Magnan, Kent K. Grindstaff, Wendy Luo, Yongjin Yao, Liang Zeng Yan
  • Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate
    Patent number: 11390581
    Abstract: Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide dihydrochloride dihydrate, methods of preparing the crystalline salt, pharmaceutical compositions containing the crystalline salt, and methods of treatment using the crystalline salt are disclosed.
    Type: Grant
    Filed: October 21, 2021
    Date of Patent: July 19, 2022
    Assignee: GEN1E LIFESCIENCES INC.
    Inventors: Adam Galan, Ritu Lal, Wendy Luo
  • P38ALPHA MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS
    Publication number: 20220162224
    Abstract: Disclosed herein are p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and therapeutic methods of using the p38? mitogen-activated protein kinase inhibitors.
    Type: Application
    Filed: February 9, 2022
    Publication date: May 26, 2022
    Inventors: ADAM GALAN, WENDY LUO, RITU LAL
  • Therapeutic peptides
    Patent number: 11332497
    Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: May 17, 2022
    Assignee: COHBAR, INC.
    Inventors: Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan
  • CRYSTALLINE 5-(DIMETHYLAMINO)-N-(4-(MORPHOLINOMETHYL)PHENYL)NAPHTHALENE-1-SULFONAMIDE DI-HYDROCHLORIDE DI-HYDRATE
    Publication number: 20220135520
    Abstract: Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide dihydrochloride dihydrate, methods of preparing the crystalline salt, pharmaceutical compositions containing the crystalline salt, and methods of treatment using the crystalline salt are disclosed.
    Type: Application
    Filed: October 21, 2021
    Publication date: May 5, 2022
    Inventors: ADAM GALAN, RITU LAL, WENDY LUO
  • P38? mitogen-activated protein kinase inhibitors
    Patent number: 11286260
    Abstract: Disclosed herein are p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and therapeutic methods of using the p38? mitogen-activated protein kinase inhibitors.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: March 29, 2022
    Assignee: GEN1E LIFESCIENCES INC.
    Inventors: Adam Galan, Wendy Luo, Ritu Lal
  • THERAPEUTIC PEPTIDES
    Publication number: 20210363187
    Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
    Type: Application
    Filed: August 4, 2021
    Publication date: November 25, 2021
    Inventors: Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan
  • P38ALPHA MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS
    Publication number: 20210355135
    Abstract: Disclosed herein are p38? mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and therapeutic methods of using the p38? mitogen-activated protein kinase inhibitors.
    Type: Application
    Filed: May 14, 2021
    Publication date: November 18, 2021
    Inventors: ADAM GALAN, WENDY LUO, RITU LAL
  • Therapeutic peptides
    Patent number: 11111271
    Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: September 7, 2021
    Assignee: COHBAR, INC.
    Inventors: Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan
  • THERAPEUTIC PEPTIDES
    Publication number: 20200181197
    Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
    Type: Application
    Filed: September 27, 2017
    Publication date: June 11, 2020
    Inventors: Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan
  • METHODS AND APPARATUS TO MINIMIZE THE EFFECT OF TAPE TENSION IN ELECTRONIC DEVICE POLISHING
    Publication number: 20100105294
    Abstract: Methods and apparatus are provided for reducing tension on a polishing roller. In some aspects, a polishing head may be provided that is adapted to contact a substrate. The polishing head includes: a polishing unit having a polisher and at least one pair of tension distributors adapted to reduce tension on the polisher; and one or more pairs feed guides. Numerous other aspects are provided.
    Type: Application
    Filed: October 22, 2009
    Publication date: April 29, 2010
    Applicant: APPLIED MATERIALS, INC.
    Inventors: Gary C. Ettinger, Wendy Luo, Antoine P. Manens